| Literature DB >> 35521357 |
L Zainab1, K Ibrar1, A Sadiq1, A K Hamid2, Midrar Ullah3, R Noor4.
Abstract
In human diet, poultry meat is an important component due to the presence of vitamins, proteins and minerals. But poultry meat can be contaminated by pathogenic bacteria which are responsible for food borne infections. The current study was therefore aimed at identification of Escherichia coli, a common pathogen causing food borne infections, in chicken samples (n = 400) collected from three districts of KhyberPukhtunkhwa; Peshawar, Kohat and Nowshera. The isolates were identified by Gram staining, API strips and through PCR (Universal Stress Protein). A total of 174 samples were positive for E. coli among the collected chicken samples. The isolates were resistant to TE, NOR and NA while were sensitive to MEM, TZP and FOS. The results were statistically significant having value P ≤ 0.05 in ANOVA. The isolates showed different antibiotic resistance genes; OXA-1, CTX-M15, blaTEM, QnrS, TetA, AAC, AAD, sul1 and sul2 which is the molecular explanations of their antibiotic resistance pattern. The PCR products were sequenced by Next Generation Sequencing (NGS) and the results revealed mutations in AAC gene (M120T and R197T) and CTX-M15 (A85V, N122D, A148S and G247D). To prevent and treat pathogenic diseases, the use of antimicrobial agents in animal husbandry are of utmost concern. The over-use and misuse of antimicrobial agents has made pathogenic E. coli multi drugs resistant making it a causative agent for many diseases in human beings. The results of the current study may be helpful for the physicians the better management of the diseases caused by E. coli.Entities:
Keywords: Antibiotic sensitivity pattern; Beta lactamases; Chicken; Escherichia coli; Resistant genes
Year: 2022 PMID: 35521357 PMCID: PMC9065911 DOI: 10.1016/j.sjbs.2022.103280
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
List of antibiotics used in the present study.
| S. No | Antibacterial Agent (abbreviations) | Sensitive (mm) | Intermediate (mm) | Resistant (mm) |
|---|---|---|---|---|
| 1 | Cefotaxime(CTX) | ≥=26 | 23–25 | ≤=22 |
| 2 | Colistin(CT) | ≥=2 | – | ≤=2 |
| 3 | Amikacin(AK) | ≥=17 | 15–16 | ≤=14 |
| 4 | Cefepime(FEP) | ≥=25 | 19–24 | ≤=18 |
| 5 | Meropenem(MEM) | ≥=23 | 20–22 | ≤=19 |
| 6 | Amoxicillin + Clavulanic acid (AMC) | ≥=18 | 14–17 | ≤=13 |
| 7 | Trimethoprim-Sulfamethoxazole(SXT) | ≥=16 | 11–15 | ≤=10 |
| 8 | Fosfomycin(FOS) | ≥=16 | 13–15 | ≤=12 |
| 9 | Norfloxacin(NOR) | ≥=17 | 13–16 | ≤=12 |
| 10 | Gentamicin (CN) | ≥=15 | 13–14 | ≤=12 |
| 11 | Cefoperazone/Sulbactam(SCF) | ≤ 10 | 11–15 | ≥ 16 |
| 12 | Ceftriaxone(CRO) | ≥=23 | 20–22 | ≤=19 |
| 13 | Ciprofloxacin (CIP) | ≥=21 | 16–20 | ≤=15 |
| 14 | Nalidixic Acid(NA) | ≥=19 | 14–18 | ≤=13 |
| 15 | Piperacillin/Tazobactam(TZP) | ≥=21 | 18–20 | ≤=17 |
| 16 | Ceftazidime(CAZ) | ≥=21 | 18–20 | ≤=17 |
| 17 | Tetracycline(TE) | ≥=15 | 12–14 | ≤=11 |
Determination of MICs using different E-test strips.
| Antibiotics | Symbols | MIC Strips | Breakpoints | ||
|---|---|---|---|---|---|
| S | I | R | |||
| Cefotaxime | CTX | E – CT | ≤ 1 | 2 | ≥ 4 |
| Co-Trimoxazole | SXT | E – TS | ≤ 2/38 | – | ≥ 4/76 |
| Meropenem | MEM | E – MP | ≤ 1 | 2 | ≥ 4 |
| Ciprofloxacin | CIP | E – CL | ≤0.25 | 0.5 | ≥ 1 |
| Amikacin | AK | E – AK | ≤ 16 | – | 64 |
| Gentamicin | CN | E – GM | ≤ 4 | 8 | ≥ 16 |
| Ceftazidime | CAZ | E – TZ | ≤ 4 | 8 | ≥ 16 |
Key: S = Sensitive, I = Intermediate, R = Resistant.
Sequences of primers, along with optimized conditions, used in the current study (Wen-juanLiang et al., 2018).
| Gene | Specific Primers | Product Size (bp) | Annealing Temperature (oC) | Cycles |
|---|---|---|---|---|
| BLA-TEM 1 | 297 | 55 for 30 sec | 35 | |
| Qnr-S | 550 | 55 for 30 sec | 35 | |
| TET-A | 577 | 58 for 30 sec | 35 | |
| CTXM 15 | 586 | 52 for 30 sec | 35 | |
| OXA 1 | 814 | 57 for 30 sec | 35 | |
| AAC | 482 | 58 for 30 sec | 35 | |
| SUL 1 | 822 | 58 for 30 sec | 35 | |
| SUL 2 | 435 | 58 for 30 sec | 35 | |
| AAD | 282 | 58 for 30 sec | 35 |
Fig. 1Different bacterial isolates from district Peshawar.
Fig. 2Different bacterial isolates from district Kohat.
Fig. 3Different bacterial isolates from district Nowshera.
Fig. 4Gel image of USP (884 bp) for identification of E. coli.
Percentage of antibiotic sensitivity pattern of E. coli isolates.
| S. No | Abbreviations | Sensitive (%) | Resistant (%) | Intermediate (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| District Peshawar | ||||||||||
| S | L | M | S | L | M | S | L | M | ||
| 1 | MEM | 46.6 | 31.2 | 27.2 | 10 | 12.5 | 18.1 | 43.3 | 46.8 | 45.4 |
| 2 | CAZ | 26.6 | 18.7 | 12.1 | 26.6 | 31.2 | 48.4 | 46.6 | 46.8 | 30.3 |
| 3 | CTX | 20 | 18.7 | 18.1 | 53.3 | 71.8 | 66.6 | 26.6 | 12.5 | 18.1 |
| 4 | AK | 23.3 | 9.3 | 21.2 | 50 | 71.8 | 54.4 | 23.3 | 21.8 | 21.2 |
| 5 | SCF | 33.3 | 18.7 | 15.1 | 33.3 | 34.3 | 36.3 | 33.3 | 46.8 | 54.4 |
| 6 | NA | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 7 | CT | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 8 | TE | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 9 | AMC | 0 | 0 | 3 | 93.3 | 100 | 93.3 | 6.6 | 0 | 3.3 |
| 10 | SXT | 10 | 9.3 | 12.1 | 86.6 | 78.1 | 90.9 | 0 | 3.1 | 0 |
| 11 | CIP | 0 | 0 | 3.3 | 76.6 | 81.2 | 75.7 | 13.3 | 15.6 | 15.1 |
| 12 | CRO | 16.6 | 18.7 | 6 | 40 | 40.6 | 51.5 | 16.6 | 43.7 | 45.4 |
| 13 | NOR | 3.3 | 0 | 0 | 96.6 | 100 | 100 | 0 | 0 | 0 |
| 14 | TZP | 33.3 | 21.8 | 18.1 | 30 | 31.2 | 39.3 | 36.6 | 46.8 | 42.4 |
| 15 | FOS | 73.3 | 53.1 | 72.7 | 20 | 34.3 | 21.2 | 6.6 | 12.5 | 6 |
| 16 | FEP | 86.6 | 15.6 | 9 | 13.3 | 34.3 | 48.4 | 0 | 50 | 51.5 |
| 17 | CN | 6.6 | 6.2 | 12.1 | 93.3 | 90.6 | 84.8 | 0 | 0 | 3.1 |
| 1 | MEM | 20.5 | 36.3 | 33.3 | 71.7 | 51.5 | 57.5 | 7.6 | 12.1 | 9 |
| 2 | CAZ | 12 | 21.2 | 12.1 | 87.8 | 78.7 | 87.8 | 0 | 0 | 0 |
| 3 | CTX | 12 | 15 | 18 | 89.7 | 71.7 | 81.8 | 0 | 0 | 0 |
| 4 | AK | 0 | 6 | 0 | 100 | 93.9 | 100 | 0 | 0 | 0 |
| 5 | SCF | 7.6 | 3 | 9 | 92.3 | 90.9 | 90.9 | 0 | 0 | 0 |
| 6 | NA | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 7 | CT | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 8 | TE | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 9 | AMC | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 10 | SXT | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 11 | CIP | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 12 | CRO | 0 | 12.1 | 21.2 | 100 | 87.8 | 78.7 | 0 | 0 | 0 |
| 13 | NOR | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| 14 | TZP | 30.7 | 12.1 | 6 | 69.2 | 69.2 | 93.9 | 0 | 6 | 0 |
| 15 | FOS | 12.1 | 3 | 15.1 | 89.7 | 96.9 | 78.7 | 0 | 0 | 6 |
| 16 | FEP | 17.9 | 12.1 | 27.2 | 79.4 | 81.8 | 72.7 | 2.5 | 6 | 0 |
| 17 | CN | 0 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
Minimum Inhibitory Concentration of different antibiotics against ESBL producing E. coli.
| Antibiotics | MIC50 (µg/ml) | MIC90 (µg/ml) | MIC Range (µg/ml) |
|---|---|---|---|
| CTX | 64 | 256 | 4–256 |
| CAZ | 128 | 256 | 16–256 |
| MEM | 0.19 | 0.75 | 0.25–1 |
| CN | 4 | 16 | 0.38–140 |
| AK | 32 | 256 | 0.25–256 |
| CIP | 16 | 256 | 0.38–256 |
| SXT | 24 | 256 | 1.0–256 |
Fig. 5CTXM 15: 1; DNA Ladder, 2; positive control, 3–9; positive for CTXM-15 (bp = 586), b. TEM 1: 1; DNA Ladder, 2–9; positive for TEM 1 (bp = 297), c. OXA 1: 1; DNA Ladder, 2; positive control, 3–9 positive for OXA 1 (bp = 814), d.TET A: 1; DNA Ladder, 2; positive control, 3–9; positive isolates for TET A (bp = 577), e. QNRS: 1; DNA Ladder, 2–9; positive isolate for QNR S (bp = 550), f. AAC(6)-Ib-cr: 1; DNA Ladder, 2–9 positive isolate for AAC(6)-Ib-cr (bp = 482), g. SUL 1: 1; DNA Ladder, 2–9; positive isolate for SUL 1 (bp = 822), h. SUL 2: 1; DNA Ladder, 2–9 positive isolate for SUL 2 (bp = 435), i. aad A1: 1; DNA Ladder, 2–9 positive isolate for aad A1(bp = 282).
Number of resistant genes in E. coli isolates of selected districts.
| Sample No | CTXM 15 | TEM 1 | OXA 1 | TET A | QNRs | SUL 1 | SUL 2 | AAC | AAD |
|---|---|---|---|---|---|---|---|---|---|
| S1 | + | − | + | + | + | − | − | + | − |
| L11 | + | − | + | + | + | − | + | − | + |
| M14 | + | + | − | + | + | + | + | + | − |
| S17 | + | − | − | + | + | + | + | − | + |
| L20 | + | − | + | + | + | + | + | − | + |
| M20 | + | − | + | + | + | + | + | + | + |
| S23 | + | + | + | + | + | + | + | + | − |
| L25 | − | − | + | + | + | − | − | − | + |
| M28 | − | − | − | + | + | − | − | − | + |
| S34 | − | − | − | + | + | + | − | − | + |
| L38 | + | − | + | + | + | + | + | + | + |
| M35 | + | + | + | + | + | − | − | + | + |
| S40 | + | − | − | + | + | + | + | − | − |
| L42 | + | − | − | − | − | + | − | − | + |
| M43 | + | − | − | + | − | − | + | + | − |
| Kohat | |||||||||
| 21L | + | − | + | + | + | + | + | + | + |
| 3L | + | + | + | + | + | − | + | + | + |
| 6S | + | + | + | + | + | − | + | − | + |
| 7M | + | − | + | + | + | + | − | − | + |
| 14S | − | + | − | + | + | − | − | + | + |
| 15M | − | + | − | + | + | − | + | + | − |
| 20S | − | − | − | + | + | + | − | + | − |
| 24L | + | + | − | + | + | + | + | + | − |
| 28M | + | − | − | + | + | − | − | + | − |
| 30L | + | + | + | + | + | + | + | − | + |
| 33M | + | + | + | + | + | + | + | − | + |
| 37L | − | + | + | + | + | − | + | − | + |
| 38S | − | − | − | + | + | + | − | + | − |
| 42L | + | + | − | + | + | + | − | + | − |
| 44S | + | + | − | + | + | + | + | + | − |
| 50M | + | − | + | + | + | − | + | + | − |
Synonymous and non-synonymous mutations.
| Nucleotide position | Reference - altered amino acid | Amino acid | Amino acid position |
|---|---|---|---|
| 400 | CCT – CCA | P | 134 |
| 405 | GTC – GTT | V | 135 |
| Codon position | Reference amino acid (Sequence) | Altered amino acid (Sequence) | Altered Amino acid Position |
| 359 | M (ATG) | T (ACG) | 120 |
| 590 | R (AGA) | T (ATA) | 197 |
| Codon position | Reference amino acid | Altered amino acid | Altered Amino acid Position |
| 254 | A (GCG) | V(GTG) | 85 |
| 364 | N (AAT) | D (GAT) | 122 |
| 442 | A (GCT) | S (TCT) | 148 |
| 740 | G (GGC) | D (GAC) | 247 |
| Nucleotide position | Reference - altered amino acid | Amino acid | Amino acid position |
| 328 | CTT – TTG | L | 110 |
| 597 | CGG – CGT | R | 199 |
| 624 | GGC – GGT | G | 208 |
I-Mutant software prediction result.
| Wild type | New type | I-Mutant prediction effect | Reliability Index (RI) | pH | Temperature (°C) |
|---|---|---|---|---|---|
| Cysteine | Threonine | Increase | 4 | 7 | 25 |
| Arginine | Threonine | Increase | 1 | 7 | 25 |
| Cysteine | Valine | Increase | 1 | 7 | 25 |
| Alanine | Aspartic acid | Decrease | 3 | 7 | 25 |
| Glycine | Serine | Decrease | 2 | 7 | 25 |
| Glycine | Aspartic acid | Decrease | 3 | 7 | 25 |